SCHEMBL493004

SCHEMBL493004

OCc1nsc2ncccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.46
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 4/20 0.40
LMNA P02545 2/20 0.40
NPC1 O15118 1/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
LIMK1 P53667 2/20 0.36
IKBKB O14920 1/20 0.36
CHUK O15111 1/20 0.36
GRM4 Q14833 1/20 0.34
MAPT P10636 2/20 0.34
KAT2B Q92831 4/20 0.33
CDC7 O00311 1/20 0.33
CLK1 P49759 1/20 0.33
DBF4 Q9UBU7 1/20 0.33
TP53 P04637 2/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL492512 0.81 KDM4E (0.34) L3MBTL1ALDH1A1KDM4ELMNANPC1
SCHEMBL24835668 0.81 GRM4 (0.43) L3MBTL1ALDH1A1KDM4ENPC1GRM4
SCHEMBL4884908 0.75 LIMK1 (0.39) L3MBTL1ALDH1A1KDM4ELMNANPC1
SCHEMBL4158596 0.71 MAPT (0.50) ALDH1A1KDM4ELMNAHTTLIMK1
SCHEMBL4895675 0.71 KAT2B (0.39) L3MBTL1ALDH1A1KDM4ELMNANPC1
SCHEMBL19141271 0.71 KDM4E (0.50) ALDH1A1KDM4EMAPT
SCHEMBL492415 0.71 NPC1 (0.43) L3MBTL1KDM4ELMNANPC1HTT
SCHEMBL2976564 0.71 KAT2B (0.39) L3MBTL1ALDH1A1KDM4ELMNANPC1
SCHEMBL492026 0.69 KDM4E (0.47) L3MBTL1ALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL29593270 0.67 L3MBTL1 (0.61) L3MBTL1ALDH1A1KDM4ELMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8273891-B2 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof MEMORY PHARMACEUTICALS CORPORATION (US) 2012-09-25 US disclosed
US-8106066-B2 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof MEMORY PHARMACEUTICALS CORPORATION (US) 2012-01-31 US disclosed
US-20100137288-A1 INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, AND PREPARATION AND USES THEREOF SCHUMACHER RICHARD 2010-06-03 US disclosed
EP-1940833-A1 INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, AND PREPARATION AND USES THEREOF Memory Pharmaceuticals Corporation (US) 2008-07-09 EP disclosed
US-20070078147-A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof MEMORY PHARMACEUTICALS CORPORATION 2007-04-05 US disclosed
WO-2007038367-A1 INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, AND PREPARATION AND USES THEREOF MEMORY PHARMACEUTICALS CORPORATION (US) 2007-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137288-A1 INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, AND PREPARATION AND USES THEREOF CHRNA7, CHRNA5, CHRNA2 L3MBTL1 3605/4885ALDH1A1 1707/4885KDM4E 3529/4885
US-20070078147-A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof CHRNA7, CHRNA5, CHRNA2 L3MBTL1 3605/4885ALDH1A1 1707/4885KDM4E 3529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.